Identifying prognostic biomarkers for palbociclib add-on therapy in fulvestrant-resistant breast cancer using cell-free DNA sequencing.
Takeshita T, Iwamoto T, Niikura N, Watanabe K, Kikawa Y, Kobayashi K, Iwakuma N, Okamura T, Tada H, Ozaki S, Okuno T, Toh U, Yamamoto Y, Tsuneizumi M, Ishiguro H, Masuda N, Saji S.
Takeshita T, et al. Among authors: okuno t.
ESMO Open. 2024 Apr;9(4):102385. doi: 10.1016/j.esmoop.2024.102385. Epub 2024 Feb 21.
ESMO Open. 2024.
PMID: 38387111
Free PMC article.